LEUKEMIA DIAGNOSTIC PANEL: AML CHARACTERIZATION

The Leukemia evaluation employs cell surface markers to aid in the diagnosis and characterisation of neoplasms of hematopoietic origin. Results are useful in the differential diagnosis, therapeutic monitoring and detection of relapses of these neoplasms.

  • Test Type:
  • Pre-test Information:
    Clinical History Mandatory.
  • Report Delivery:
    Sample Daily by 9 am; Report Same day
  • Components:
    0

Sample Report

leukemia diagnostic panel aml characterization in other Cities